News Industry News Cook Medical Provides Patient-Level Paclitaxel Data From Randomised Control Trial April 19, 2019
News Industry News Zilver® PTX® with Thumbwheel Delivery System Launched in France September 23, 2016
News Industry News Boston Scientific Receives CE Mark For Eluvia™ Drug-Eluting Vascular Stent and Announces Initiation of New Clinical Trial February 21, 2016
News Industry News First U.S. Patient Treated Following FDA Approval of Cook Medical’s Zenith Alpha™ Thoracic Endovascular Graft January 25, 2016
News Industry News Cook Medical Expands Global Recall of Select Sizes of Beacon Tip Angiographic Catheters October 12, 2015
News Industry News Cook Medical Receives FDA Approval for the Zenith Alpha™ Thoracic Endovascular Graft September 18, 2015
News Industry News Cook Medical Issues Global Recall of Beacon Tip Angiographic Catheter Products August 04, 2015
News Industry News New All-Comers Study Compares Efficacy of Bioresorbable Vascular Scaffold to Best-in-Class Drug Eluting Stents September 16, 2014
News Industry News Symetis receives CE Mark approval for transfemoral transcatheter aortic heart valve system ACURATE neo™, and launches product with first commercial implantations September 12, 2014
News Industry News Cook Medical's Zilver® PTX® Drug-Eluting Stent selected as a top emerging health technology in Canada July 25, 2014
News Industry News Cook Medical reintroduces its Evolution® RL lead extraction products to the United States market July 10, 2014
News Industry News Cook Medical makes Zilver® PTX® drug-eluting stent available in Canada June 05, 2014
News Industry News Postmarket surveillance study in Japan confirms benefits of Cook Medical's Zilver® PTX® stent May 29, 2014
News Industry News Zilver PTX randomized trial of paclitaxel-eluting stents for femoropopliteal disease demonstrates superior results February 13, 2014
News Industry News CardioKinetix Initiates Landmark Study of First-of-Its-Kind Treatment for January 07, 2013
News Industry News Cook Medical’s Zilver® PTX® Earns FDA Approval As First Drug-Eluting Stent in U.S. to Treat Peripheral Arterial Disease November 14, 2012
News Industry News NSVascular, Inc., a NeuroSigma Subsidiary, Signs an Exclusive License Covering UCLA's Thin-Film Nitinol (TFN) Stent Technology for Endovascular Applications July 18, 2011